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Abstract
The last years of research have proposed that bacteria might be involved in and contribute to the lack of healing of chronic
wounds. Especially it seems that Pseudomonas aeruginosa play a crucial role in the healing. At Copenhagen Wound Healing
Centre it was for many years clinical suspected that once chronic venous leg ulcers were colonized (weeks or months
preoperatively) by P. aeruginosa, the success rate of skin grafting deteriorated despite aggressive treatment. To investigate
this, a retrospective study was performed on the clinical outcome of 82 consecutive patients with chronic venous leg ulcers
on 91 extremities, from the 1
st of March 2005 until the 31
st of August 2006. This was achieved by analysing the
microbiology, demographic data, smoking and drinking habits, diabetes, renal impairment, co-morbidities, approximated
size and age of the wounds, immunosuppressive treatment and complicating factors on the clinical outcome of each
patient. The results were evaluated using a Student T-test for continuous parameters, chi-square test for categorical
parameters and a logistic regression analysis to predict healing after 12 weeks. The analysis revealed that only 33,3% of
ulcers with P. aeruginosa, isolated at least once from 12 weeks prior, to or during surgery, were healed (98% or more) by
week 12 follow-up, while 73,1% of ulcers without P. aeruginosa were so by the same time (p=0,001). Smoking also
significantly suppressed the outcome at the 12-week follow-up. Subsequently, a logistic regression analysis was carried out
leaving P. aeruginosa as the only predictor left in the model (p=0,001). This study supports our hypothesis that P.
aeruginosa in chronic venous leg ulcers, despite treatment, has considerable impact on partial take or rejection of split-
thickness skin grafts.
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Introduction
In Denmark, it has been estimated that the prevalence of non-
healing wounds is about 1% of the population. The prevalence
and incidence of leg ulcers are similar to elsewhere in the in-
dustrialized world[1]. This has large socio-economic costs. The
total expenses for treatment of wounds are estimated to be
approximately 2% to 3% of the total budget of the health care
system in Denmark[2]. Meshed Split Thickness Skin Grafts
(STSGs) are widely used in the treatment of non-healing leg ulcers.
The technique of meshing STSGs was first reported in 1964[3].
The clinical outcome of skin grafting depends on a variety of
factors, some more substantiated than others. Only a limited
number of publications on skin graft loss due to infection exist and
they are mostly related to the management of burn wounds. A
number of the studies have focused on the importance of
quantitative rather than qualitative bacteriology others vice versa.
From the literature it can be deducted that a successful skin graft
‘‘take’’ is less likely to occur on experimental or clinical wounds
that contain more than 10
5 viable bacteria per gram of tissue[4,5].
The majority of publications discussing qualitative bacteriology
point out haemolytic streptococci in particular Streptococcus pyogenes
as the predominant species leading to graft lysis[6–10]. Graft lysis
due to non-group A beta-haemolytic streptococci has also been
reported[11] together with Staphylococcus aureus [12] and Pseudomo-
nas aeruginosa[8,12–16].
Skin graft failure due to P. aeruginosa is not a novel hypothesis.
It was proposed in 1951[17]. Since then, there have been only few
articles published concerning this issue. The hypothesis was
confirmed by Gilliland et al[12] more than 20 years ago, stating
the isolation of Pseudomonas from an ulcer prior to skin grafting
significantly impairs skin graft take.
Despite this knowledge it still seems to be a problem of high
relevance.
It is our clinical experience during our daily work with chronic
venous leg ulcers and STSGs that once the ulcers are colonized by
P. aeruginosa, even weeks or months preoperatively, the success rate
of skin grafting deteriorates. This, in spite of an aggressive
treatment, in our clinic, of P. aeruginosa, in the form of extensive
debridement of the wound bed before grafting often combined
with systemic antibiotic therapy. Our focus on P. aeruginosa has
increased over time due to increasing evidence of this bacterium to
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have elucidated P. aeruginosa as being present in the wounds as
biofilms in many of our patients, see Figure 1[18–20]. The ability
of colonizing bacteria to establish themselves and proliferate in a
biofilm could be the cause of the lack of successful antibiotic
treatment. Currently we are changing our antibiotic regime to
accommodate the eradication of bacteria in biofilms. In order to
evaluate the impact of P. aeruginosa on graft take in our present
antibiotic regimen we chose to make a retrospective study to
establish the relevance of the subject prior to further investigation.
Our aim of this study was to determine whether graft take and
survival of the graft, in the first 3 months, was dependent on
wound bed bacteriology from 12 weeks prior, to or during surgery,
with particular attention to P. aeruginosa.
Materials and Methods
Patients
A retrospective study was conducted of consecutive patients who
underwent meshed split-thickness skin grafting for chronic venous
leg ulcers in Copenhagen Wound Healing Centre, Bispebjerg
Hospital, Denmark, over a period of 18 months from the 1
st of
March 2005 until the 31
st of August 2006. The centre consists of a
team of expert wound care specialists[1,9]. Data was collected
from the medical records.
Ninety-five patients received autografting with meshed split-skin
transplants of their lower leg ulcers of venous origin as the
apparent aetiology. Thirteen of the 95 patients were excluded in
our analysis. The main reason being lack of data due to their
absence at the 12-week follow-up: Six patients passed away for
unrelated causes in the weeks following surgery. One patient did
not attend the outpatient clinic until after 9 months and 3 patients
only attended it once or twice but missed out on the final
appointments including the 12-week follow-up. Moreover, 2
patients exhibited pronounced non-compliance, which led to
immediate rejection of the transplants and, finally, one patient was
excluded due to a total lack of microbiology data. A total of 9 of
the 82 patients included in our analysis required a second or third
grafting during the study period for the treatment of recurrent or
new ulcers. Only the first ulcer episode was included. Of the
included patients, 22 had bilateral ulcers. Of these, only 9 patients
were included in the study with bilateral ulcers and the remaining
13 were included with unilateral ulcers due to insufficient data as
regards to which leg the microbiology was achieved from. This
selection enabled us to perform an exact statement on whether or
not P. aeruginosa had been isolated from that particular leg. Cases of
multiple ulcers and concurrent grafts on one leg were treated as a
single event. In about 70% of the cases there was only 1 ulcer per
leg. As to the other listed bacteria in the bilateral cases, it has been
necessary to assume, that the microbiology assessed was identical
in the 2 extremities. Overall the study includes 82 patients (91
extremities).
Venous origin of the ulcers was classified according to a history
of past thrombophlebitis or varicectomy and characteristic clinical
signs of venous insufficiency. Moreover, the origin was often
confirmed by Colour Duplex Vein scan findings[21]. In case of
absent pedal pulse, we defined sufficient blood supply (by stain
gauge) as an ankle pressure more than 70 mmHg and/or toe
pressure more than 50 mmHg, taking the location of the wounds
into account.
Ethics
An application was sent to the Ethical Comity for Copenhagen
and the Danish National Board of Health and the present study
did not need approval as only anonymous data were used and that
no informed consents from the patients were needed.
Grafting
Our grafting methods and procedures have been described
previously by Bitsch et al[9] but are briefly as follows: tangential
excision of their leg ulcers followed by autografting with meshed
STSGs (Figure 1 and 2). This entailed mechanical debridement of
necrotic tissues, lipodermatosclerotic skin, exposed tendons,
subcutaneous calcifications and bone immediately followed by
mesh skin grafting. Mesh grafting consists of harvesting a STSG
(0,3 mm thick) with a dermatome and expanding this graft with a
mesher. Insufficient perforator veins are ligated superficially to the
fascia. Donor grafts are obtained from the thigh. In addition,
immobilizing devices are used if skin grafts are applied on to
mobile surfaces. The vast majority of the patients are discharged
after an average period of 7–10 days. Compression therapy is
continued after discharge. Early standard postgraft follow-up
consists of 3 controls, in the 3
rd,6
th and 12
th week in the outpatient
clinic.
Bacteriology
We have examined the bacteriology assessed from the wounds
from 12 weeks prior, to and during surgery. The ulcer surfaces
were swabbed with a sterile charcoal swab preoperatively. During
Figure 1. A venous leg ulcer at time of operation. Standard state-
of-the-art treatment failed to heal the ulcer and according to our
protocol the patient was offered a revision and split-skin transplant.
doi:10.1371/journal.pone.0020492.g001
Figure 2. The same ulcer as Figure 1 five weeks post operative.
The spit-skin transplant is well attached and almost completely healed.
doi:10.1371/journal.pone.0020492.g002
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microbiology assessment was either detected by a charcoal swab or
by a biopsy. The swabs or mechanically crushed tissue were
cultured on aerobic and anaerobic standard agar plates (Statens
Serum Institute [SSI], Copenhagen, Denmark). The aerobic
cultures were grown on selective gram-negative plates (blue plates;
SSI) as well as 5% horse blood agar (SSI) and incubated at 35uC.
The anaerobic cultures were grown on anaerobic plates (SSI) and
incubated under anaerobic conditions in anaerobic chamber at
35uC. All plates were inspected on days 1 and 2. Identification of
bacteria was performed using standard methods including selective
growth on relevant agar plates, VITEK 2 and API diagnostic
strips. The following bacteria have been the issue of interest: P.
aeruginosa, Pseudomonas species, S. aureus, haemolytic Streptococci
(group A, B, C, G), Proteus, gram-negative bacilli and anaerobic
bacteria.
Antibiotic treatment
Systemic antibiotics were provided if necessary and in accor-
dance with the microbiology assessed from the wounds. Routinely
either cefuroxime 1500 mg alone or in combination with
gentamicin 160–240 mg were administered intravenously as single
shots perioperatively. The majority of patients with P. aeruginosa
either received ciprofloxacin (typically 500 mg orally x 2) alone or
in combination with one of the following: meropenem (2 g x 3), a
combination of piperacillin and tazobactam (4 g x 3), ceftazidim
(1 g x 2) or gentamicin (160–240 mg x 1) intravenously of varying
periods. In addition, the majority was treated with silver con-
taining dressings preoperatively.
Evaluation
The clinical outcome was evaluated, as percentages of graft take
observed at the routine check-ups in the first 3 months with
emphasis on the 12
th week follow-up. Graft take was divided into
two groups: healed versus not-healed, with five subgroups in total.
The healed category was divided into two subgroups. Completely
healed, [100%], and 98% or more, [98%–100%], of the grafted
skin intact with defects thought to be insignificant. The not-healed
category was divided into three subgroups: less than 98% but more
than 75% take, [75%–98%], 75% or less but more than 5% take,
[5%–75%], and finally 5% or less, [0–5%]. The coding clas-
sification for healing is subjective nevertheless it is problematic to
use the term 100% healed when working with STSGs. Technically,
it is almost impossible to avoid very small and clinical insignificant
defects during the procedure itself and the following rehabilitation.
We have chosen 98% or more as a healed category with defects
thought to be insignificant because that is what seemed reasonable
for what could be classified very successful.
Three of the authors (TH, JST and KKM) evaluated the
percentages of graft take in order to test the reproducibility of data.
The evaluators randomly selected 25% of the cases and achieved
conformity of 100%.
The long-term outcome was recorded as the last known con-
dition of the ulcer documented in the medical records until an
eventual new operation.
Co-morbidities were identified. The major groups were: ische-
mic heart disease, chronic obstructive pulmonary disease, stroke
with sequelae, congestive heart failure, cancer, rheumatoid arthri-
tis, scleroderma, chronic anaemia and drug addiction. Diabetes
mellitus and chronic renal impairment were listed separately to-
gether with the use of immunosuppressive drugs (prednisone,
ciclosporin or azathioprin).
Sex, age, smoking and drinking habits, approximated age and
size of the wounds and complicating factors for wound healing like
exposed bone, bare tendon or involvement of the achilles region
were registered. Smoking refers to smoking habits on the day of
hospitalization, typically a few days prior to surgery. Drinking
habits were only recorded if the number of drinks per week was
higher than what the Danish Health Department recommends.
This is no more than 21 drinks per week for men (max 252 g/wk)
and no more than 14 drinks per week for women (max 168 g/wk).
PNA FISH
Tissue section of a chronic wound was analyzed by fluorescence
in situ hybridization (FISH) using peptide nucleic acid (PNA)
probes (Figure 3). A Texas Red-labeled P. aeruginosa-specific PNA
probe in hybridization solution (AdvanDx, Inc., Woburn, MA),
was added to each section and hybridized in a PNA FISH
workstation covered by a lid at 55uC for 90 min. The slides were
washed for 30 min at 55uC in wash solution (AdvanDx). Three-
dimensional imaging of the bacteria in the wounds was done by
confocal laser scanning microscopy (CLSM) using a Zeiss LSM
510 system (Carl Zeiss GmbH, Jena, Germany) equipped with
ahelium-neon laser for excitation of the fluorophores. Simulated
fluorescence projections of the biofilms were generated by using
the IMARIS software package (Bitplane AG). Images were further
processed for display by using Photoshop software (Adobe).
Statistical analysis
The statistical program used was SPSS version 15.0. Patient and
wound characteristics were compared between the groups by
means of Student T-test for continuous parameters and chi-square
(or Fisher Exact) test for categorical parameters. Finally, a logistic
regression analysis was performed using forward stepwise method
to predict healing after 12 weeks.
Results
The patients studied consist of 82 patients (91 extremities) with
45 women (54,9%) and 37 men (45,1%). The average (SD) age was
69,5 (13,5) years ranging from 39 to 92 years. Diabetes was present
in 15 patients (18,3%). Twenty patients were smokers (24,7%) and
10 patients (12,2%) had excessive alcohol consumption as
described earlier. The average interval between grafting and the
12-week follow-up was 13,0 (2,8) weeks ranging from 7–22 weeks.
The average interval from grafting to ‘‘long-term outcome’’ was
57,4 (33,5) weeks ranging from 11–145 weeks. The approximated
average age of the ulcers before surgery was 12,8 (15,7) months
(range: 3 weeks–9 years) and the approximated average size of a
single (if solitary) or concomitant ulcers on one extremity was
102,6 (118,1) cm2 (range: 3 cm2–600 cm2).
Healing and bacteriology
As for the healing, interestingly only 33,3% (8/24) of ulcers with
P. aeruginosa (isolated at least once in the 12 weeks prior, to or
during surgery) were healed (98% or more) by week 12 follow-up,
while 73,1% (49/67) of ulcers without P. aeruginosa were so by the
same time (p=0,001, Chi-square test), see table 1. Looking at the
more detailed healing categories we also found significant
differences (p=0,011, Mann-Whitney), see table 2. We have used
a categorical ordinal scale to increase sensitivity in the analyses
done (compared to the merged categories healed/not healed). The
analysis of the detailed data shown in table 2 point in the same
direction as the analysis of the merged categories in table 1 as
pointed out in the article.
No statistically significant correlation could be detected between
the clinical outcome and the other microorganisms listed; S. aureus,
Pseudomonas species, anaerobic bacteria, haemolytic Streptococci,
P. aeruginosa Deteriorate Split-Skin Grafting
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consumption, diabetes, renal impairment, co-morbidities, approx-
imated size and age of the wounds, immunosuppressive treatment
or complicating factors. Moreover, these entities were evenly
distributed in the 2 groups (P. aeruginosa versus the non-P. aeruginosa
group) except from smoking and approximated age of wound. On
average, ulcers in the P. aeruginosa group were 18,3 (18,6) months
old versus 10,8 (14,1) months in the non- P. aeruginosa group
(p=0,043, Student T-test). Only 20,9% (14/67) of the ulcers
found on non-smokers, contained P. aeruginosa while 45,5% (10/22)
found on smokers (45,5%), had P. aeruginosa (p=0,024, Chi-square
test). Smoking was the only entity, that was also significant in
regards to the outcome at the 12 week follow-up with 40,9% (9/
22) of ulcers on smokers healed versus 68,7% (46/67) of ulcers on
non-smokers (p=0,020, Chi-square test). A logistic regression
analysis to predict healing at week 12 was carried out including P.
aeruginosa, diabetes, alcohol consumption, smoking and sex as
predictors. By using the forward stepwise methods on P. aeruginosa
(p=0,001, Logistics regression) it was the only predictor left in the
model (smoking was not as significant, indicating some correlation
between smoking and P. aeruginosa).
The perioperative isolation of P. aeruginosa, revealed results even
more pronounced with only 26,7% (4/15) of ulcers with P.
aeruginosa healed versus 68,2% (45/66) of them without P. aeruginosa
healed (p=0,007, Fisher’s Exact test). If P. aeruginosa was isolated at
least once in the 12 weeks prior to surgery, excluding the periop-
erative day, similar results occurred, but yet a bit less conspicuous:
Figure 3. CLSM three-dimensional image of a large P. aeruginosa biofilm in the wound bed of a chronic wound (identified by a
specific PNA FISH probe (red)).
doi:10.1371/journal.pone.0020492.g003
Table 1. Healing data of ulcers 12 weeks postoperative from
ulcers with or without P. aeruginosa.
Week 12 follow-up
results:
P. aeruginosa pre- or
perioperative
No Yes
Healed 73,10% 33,30%
[98%-100%] (49/67) (8/24)
Not healed 26,90% 66,70%
[0%-98%] (18/67) (16/24)
Table 2 is transferred into table 1 by merging categories.
P=0,001, N=91, Chi=11,96, Chi-square test.
doi:10.1371/journal.pone.0020492.t001
Table 2. Detailed healing categories at 12 weeks follow-up
divided by presence of Pseudomonas aeruginosa pre- and/or
peri-operative or not.
P. aeruginosa pre- and
/or perioperative
Week 12 follow-up results: N=67 N=24
No Yes
[0%-5%] healed 10,40% 33,30%
[ 5%-75%] healed 7,50% 12,50%
[75%-98%] healed 9,00% 20,80%
[98%-100%] healed 23,90% 0,00%
[100%] healed 49,30% 33,30%
P=0,011, Mann Whitney test.
doi:10.1371/journal.pone.0020492.t002
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64) in non-P. aeruginosa group (p=0,018, Chi-square test).
The 12 weeks healing corresponded very well to the long-term
healing. 82,2% (74/90) of the extremities that were recorded as
healed at both time points (N=47) or not healed at both time
points (N=27) remained so in these categories. The long-term
outcome in regards to the P. aeruginosa group exclusively showed
that 37% of ulcers healed with P. aeruginosa versus 68,2% without it
(p=0,009, Chi-square test).
Discussion
No unifying hypothesis can explain the loss of skin transplants.
A wide range of things are believed to adversely influence skin
graft take; haematoma or shearing movements[8], inadequate
compliance, deficient blood supply, presence of microtrombi in the
dermal blood vessels[22], local fibrin deficiency in the wound
bed[23] and former thrombophlebitis in relation to primary deep
vein incompetence[24] are examples. Skin graft loss due to
infection make up only a minor part in the literature with very few
publications on deterioration of skin grafts due to P. aeruginosa
[8,12–16], particularly in the field of chronic lower limb ulcer-
ations. These papers do not reach an agreement on the severity of
the role of P. aeruginosa. They all concentrate on microbiology
assessed immediately prior to grafting or postgrafting. To our
knowledge, the only paper with regards to leg ulcers is more than
20 years old[12]. In this paper Gilliland et al reported that the
initial swab results (at admission) were not related to the outcome
of skin grafting, it was only the presence of bacteria (Pseudomonas
and S. aureus) in the immediate preoperative or postoperative
periods that played a role. Surgical debridement was only
executed if necessary, but to what extent and details concerning
antibiotics were undocumented. Likewise, Pseudomonas was not
subdivided into species and the group of patients was heteroge-
neous by taking all leg ulcers into account despite aetiology. Unal
et al[16] found that P. aeruginosa was an equally prominent danger
as S. pyogenes in skin graft survival in routine plastic surgery
practice. They only focused on bacteriological cultures assessed
postoperatively and only obtained samples from the defected
grafts, thereby fail to elucidate what came first; P. aeruginosa or the
defects? Mc Gregor,[8] in contrast, claims that infection with P.
aeruginosa reduces graft take but not to an extent comparable with
S. pyogenes. He also stated that its presence is a nuisance rather than
a disaster and it may reduce graft takes by 5–10% at most.
In our study, the presence of P. aeruginosa was by far the best
predictive marker for the outcome of STSGs of chronic venous leg
ulcers. In other words, if P. aeruginosa was isolated at least once in
12 weeks prior, to or during surgery, it was a significant negative
predictor for the outcome of the graft. Overall, our results show,
that 33,3% of ulcers with P. aeruginosa were healed by the 12-week
follow-up, while 73,1% of ulcers without P. aeruginosa were so by
the same time. None of the other bacteria listed showed any
significant difference in the clinical outcome. Neither did age, sex,
alcohol consumption, diabetes, renal impairment, co-morbidities,
approximated size and age of the wounds, immunosuppressive
treatment or complicating factors. Smoking was the only entity
that was also significant in regards to the outcome at the 12-week
follow-up. In this perspective, it is important to remember that
almost 50% of the ulcers among smokers had P. aeruginosa.A
logistic regression analysis to predict healing at week 12 showed P.
aeruginosa as the only significant predictor left in the model
(p=0,001, Forward stepwise logistic regression), whereas sex,
diabetes, alcohol, age and smoking where insignificant. It is
generally accepted that smoking impairs wound healing[25].
Furthermore, in our study, ulcers with P. aeruginosa were sta-
tistically significant older than ulcers from where it had not been
isolated. Perhaps this could explain why ulcers on smokers, in our
study, tend to be colonized by P. aeruginosa, that wounds on
smokers heal more slowly thereby giving the time to P. aeruginosa to
settle in.
In the present study the 12-week outcome can be interpreted as
a predictor for the long-term outcome. Kirsner et al[26] reported
similar findings of a critical period of 3 months postgrafting, after
which, if the graft was intact, it tended to remain so.
It is remarkable that even with aggressive treatment of P.
aeruginosa the results evidently demonstrate a connection between
P. aeruginosa and deterioration of skin grafts. We believe that the
explanation lies in insufficient eradication of P. aeruginosa and
that it is the persistence of P. aeruginosa that deteriorates the
clinical outcome. From our clinic, Gjødsbøl et al[27], reported
that more than half of the leg ulcers (52,2%) investigated in their
study, concerning chronic venous leg ulcers, were colonized by
P. aeruginosa, thus emphasizing the importance of this issue and
the relevance in getting to the core of the problem. Also their
results indicated that it was the same strain of P. aeruginosa that
colonized the ulcers during an eight-week period, proposing that
once the ulcer was colonized it remained so. To this should be
mentioned that no antibiotics were administered in their study
period.
The lack of successful antibiotic treatment is probably ex-
plained by ability of colonizing bacteria to establish themselves
and proliferate in a biofilm. A biofilm is a multi cellular aggregate
encased in a extracellular matrix of polysaccharides, protein, DNA
etc, compared to single free swimming bacteria termed planktonic
cells[28]. The clinical implications of bacterial biofilms are
particularly pronounced in chronic infections[29]. In addition to
being highly tolerant to antibiotics, biofilms are also impervious to
the body’s natural immune defence system[15]. P. aeruginosa and S.
aureus are well recognised for forming chronic biofilm-based
infections in their hosts. Normally radical debridement of the
infected area is the treatment of choice in case of biofilm in-
fections. In this study a thorough debridement was performed
down to viable and visually non-infected tissue. Despite this,
detection of P. aeruginosa prior to surgery, reduced graft take
significantly. This indicates that P. aeruginosa resides deep down in
the tissue, and is probably protected from antibiotics and the
immune system due to biofilm formation. This is in accordance
with a study by Fazli et al[30] showing a non-random distribution
of P. aeruginosa and S. aureus where P. aeruginosa is found deeper into
the tissue than S. aureus.
The sampling for microbiology of this study was performed by
either a charcoal swab or by a biopsy. Several researchers have
previously reported that surface swabs are considered equivalent to
biopsy cultures[16] and that it reflects the microflora of deeper
tissues[31]. However, this is up for debate. Bjarnsholt et al[18]
indicated that bacteria are assembled in microcolony based
structures found in bacterial biofilms and are far from evenly
distributed within the wound, thereby implicating that cultures
from a biopsy or swab are not likely to be representative for the
total bacteriological load in the wound.
In the present study there was no correlation between the
presence of haemolytic streptococci, isolated at least once from 12
weeks prior, to or during surgery, and the outcome of the STSGs.
A part of the reason is, supposedly, due to our protocol that
ensures rapidly administration of antibiotics in regards to haemo-
lytic streptococci, in particular S. pyogenes. The reason why the
antibiotic treatment seems to eradicate these strains rather than
the P. aeruginosa probably lies in the fact that the haemolytic
P. aeruginosa Deteriorate Split-Skin Grafting
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tissue and therefore are susceptible to antibiotics.
The number of ulcers colonized by anaerobe bacteria in this
study is probably not representative of the real burden of these,
because of deficiencies in the bacteriologic investigations per-
formed. The present study has some limitations due to the
culturing methods. Conventional culturing often fails to identify all
bacteria as some are hard to grow, some are fastidious or only
present in certain parts of the wound. Previous studies have shown
that P. aeruginosa is especially underestimated by culturing methods,
probably due to their biofilm state[18,20,32,33], but this accounts
for other bacteria as well. We find that unidentified presence of
P aeruginosa could explain some of the failures in the non-
Pseudomonas group, but this remains to be pure speculation.
This study supports our hypothesis that P. aeruginosa in chronic
venous leg ulcers, despite treatment, plays a considerable role in
partial take or rejection of STSGs. Further studies on how to
eliminate P. aeruginosa in this clinical situation and if this could
improve the success rate will be needed. For biofilms, the lack of
efficient antibiotic effect seems to depend on multiple mechanisms
that can act together[28]. Further understanding of this might
provide a rational basis for therapeutic manipulation of the wound
environment that could ensure more successful skin grafting by
eradicating P. aeruginosa. Given the limitations of this retrospective
study we do recommend further studies to establish the role of
bacteria in chronic wounds. In the light of this new information,
we will strongly advise against transplanting chronic venous leg
ulcers without a strategy how to eliminate P. aeruginosa.
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